Cargando…
Interstitial Brachytherapy for Orbital Sebaceous Carcinoma
Sebaceous carcinoma is characterized by its aggressive local tumor behavior and ability to metastasize. Small periocular sebaceous carcinoma are typically treated by excision with cryotherapy. Larger tumors often require adjuvant external beam radiotherapy (EBRT) and/or exenteration surgery. When us...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565506/ https://www.ncbi.nlm.nih.gov/pubmed/34314398 http://dx.doi.org/10.1097/IOP.0000000000002031 |
_version_ | 1784593832693727232 |
---|---|
author | Li, Feng Stewart, Robert D. Finger, Paul T. |
author_facet | Li, Feng Stewart, Robert D. Finger, Paul T. |
author_sort | Li, Feng |
collection | PubMed |
description | Sebaceous carcinoma is characterized by its aggressive local tumor behavior and ability to metastasize. Small periocular sebaceous carcinoma are typically treated by excision with cryotherapy. Larger tumors often require adjuvant external beam radiotherapy (EBRT) and/or exenteration surgery. When used alone, EBRT techniques typically exceed the tolerance of critical normal ocular structures. The interstitial orbital brachytherapy-boost technique permits dose escalation to the tumor bed, while minimizing radiation dose to critical normal ocular structures. Here, we present a case of orbital sebaceous carcinoma treated with excision, cryotherapy, and super-thick amniotic membrane fornix reconstruction. Then, after 3 weeks of healing, adjuvant-combined electron interstitial high-dose rate brachytherapy-boost was added to electron-beam radiotherapy to optimize the orbital radiation dose distribution, increase dose to inferonasal orbit, and allow relative sparing of orbital tissues. At 1-year follow-up, there was no evidence of orbital tumor, no significant eye lash loss, normal ocular motility, no radiation retinopathy, optic neuropathy and a visual acuity of 20/20. |
format | Online Article Text |
id | pubmed-8565506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-85655062021-11-05 Interstitial Brachytherapy for Orbital Sebaceous Carcinoma Li, Feng Stewart, Robert D. Finger, Paul T. Ophthalmic Plast Reconstr Surg Case Reports Sebaceous carcinoma is characterized by its aggressive local tumor behavior and ability to metastasize. Small periocular sebaceous carcinoma are typically treated by excision with cryotherapy. Larger tumors often require adjuvant external beam radiotherapy (EBRT) and/or exenteration surgery. When used alone, EBRT techniques typically exceed the tolerance of critical normal ocular structures. The interstitial orbital brachytherapy-boost technique permits dose escalation to the tumor bed, while minimizing radiation dose to critical normal ocular structures. Here, we present a case of orbital sebaceous carcinoma treated with excision, cryotherapy, and super-thick amniotic membrane fornix reconstruction. Then, after 3 weeks of healing, adjuvant-combined electron interstitial high-dose rate brachytherapy-boost was added to electron-beam radiotherapy to optimize the orbital radiation dose distribution, increase dose to inferonasal orbit, and allow relative sparing of orbital tissues. At 1-year follow-up, there was no evidence of orbital tumor, no significant eye lash loss, normal ocular motility, no radiation retinopathy, optic neuropathy and a visual acuity of 20/20. Lippincott Williams & Wilkins 2021-07-27 2021 /pmc/articles/PMC8565506/ /pubmed/34314398 http://dx.doi.org/10.1097/IOP.0000000000002031 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Case Reports Li, Feng Stewart, Robert D. Finger, Paul T. Interstitial Brachytherapy for Orbital Sebaceous Carcinoma |
title | Interstitial Brachytherapy for Orbital Sebaceous Carcinoma |
title_full | Interstitial Brachytherapy for Orbital Sebaceous Carcinoma |
title_fullStr | Interstitial Brachytherapy for Orbital Sebaceous Carcinoma |
title_full_unstemmed | Interstitial Brachytherapy for Orbital Sebaceous Carcinoma |
title_short | Interstitial Brachytherapy for Orbital Sebaceous Carcinoma |
title_sort | interstitial brachytherapy for orbital sebaceous carcinoma |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565506/ https://www.ncbi.nlm.nih.gov/pubmed/34314398 http://dx.doi.org/10.1097/IOP.0000000000002031 |
work_keys_str_mv | AT lifeng interstitialbrachytherapyfororbitalsebaceouscarcinoma AT stewartrobertd interstitialbrachytherapyfororbitalsebaceouscarcinoma AT fingerpault interstitialbrachytherapyfororbitalsebaceouscarcinoma |